How is AI-MedTech in India regulated? (www.thehindu.com)

India's national telemedicine helpline, e-Sanjeevani, has incorporated an AI-enabled clinical decision support system, highlighting the growing trend of AI integration in healthcare. As AI begins influencing clinical decisions—affecting referrals, investigations, and patient reassurance—the need for robust regulation has become paramount for ensuring patient safety. The Central Drugs Standard Control Organisation (CDSCO) has announced guidance for software used as medical devices, clarifying the approval pathway for AI in medical contexts. This guidance emphasizes a risk-based regulatory framework, classifying software based on its potential impact on health outcomes. The integration of AI in medical devices raises significant challenges. Developers must provide extensive data on training, validation, and the demographic representation of AI models, ensuring they perform effectively in diverse populations, particularly in India. While the CDSCO's approach allows for swift regulation without awaiting legislative action, there are calls for establishing a dedicated statutory framework to enhance trust and accountability. As AI technologies potentially influence life-and-death decisions, discussions continue on whether they should be governed by existing guidelines or a more comprehensive legal framework that protects patients and healthcare providers alike.